Long Term Isa27 Treatment Of U87mg Cells U87mg Cells Were Treated With

Long-term ISA27 treatment of U87MG cells. U87MG cells were treated with ...
Long-term ISA27 treatment of U87MG cells. U87MG cells were treated with ...
Cell proliferation assay of U87MG. U87MG cells were treated with the ...
Cell proliferation assay of U87MG. U87MG cells were treated with the ...
Cell proliferation assay of U87MG. U87MG cells were treated with the ...
Cell proliferation assay of U87MG. U87MG cells were treated with the ...
Cell proliferation assay of U87MG. U87MG cells were treated with the ...
Cell proliferation assay of U87MG. U87MG cells were treated with the ...
Cell proliferation assay of U87MG. U87MG cells were treated with the ...
Cell proliferation assay of U87MG. U87MG cells were treated with the ...
Viability of U87MG GBM cells with TRAIL and QC. Cells were treated with ...
Viability of U87MG GBM cells with TRAIL and QC. Cells were treated with ...
U87MG cell invasiveness upon treatment with 9. U87MG cells were ...
U87MG cell invasiveness upon treatment with 9. U87MG cells were ...
U87MG cells were treated with compounds (5 μM) or DMSO (control) for ...
U87MG cells were treated with compounds (5 μM) or DMSO (control) for ...
Viability of U87MG cells after treatment with various concentrations of ...
Viability of U87MG cells after treatment with various concentrations of ...
(a) Dark-field images of U87MG cells treated with PEGylated CNTR@AuNP ...
(a) Dark-field images of U87MG cells treated with PEGylated CNTR@AuNP ...
(A) Cell viability of U87MG cells with different treatments. (B) The ...
(A) Cell viability of U87MG cells with different treatments. (B) The ...
A. U87MG cells were transduced with the indicated Ads, included in 3D ...
A. U87MG cells were transduced with the indicated Ads, included in 3D ...
GSK1838705A reduces glioma cell viability. (A) U87MG cells were treated ...
GSK1838705A reduces glioma cell viability. (A) U87MG cells were treated ...
LD22-4 inhibits the migration of U87MG cells. A, U87MG cells were ...
LD22-4 inhibits the migration of U87MG cells. A, U87MG cells were ...
SA-gal positivity of U87MG and U87MG-E6 cells incubated with either TMZ ...
SA-gal positivity of U87MG and U87MG-E6 cells incubated with either TMZ ...
(A) Representative phase-contrast micrographs of U87MG cells left ...
(A) Representative phase-contrast micrographs of U87MG cells left ...
U87MG cells did not recover normal growth upon removal of ISA27. U87MG ...
U87MG cells did not recover normal growth upon removal of ISA27. U87MG ...
A. Morphology of untreated U87MG and U87-MCSF cells. U87-MCSF cells ...
A. Morphology of untreated U87MG and U87-MCSF cells. U87-MCSF cells ...
(A) Images of U87MG cells at the indicated times after transfection ...
(A) Images of U87MG cells at the indicated times after transfection ...
Cellular uptake and relative viability of U87MG cells after incubation ...
Cellular uptake and relative viability of U87MG cells after incubation ...
Growth and viability of U87MG and U87MG.D2-7 cells in different ...
Growth and viability of U87MG and U87MG.D2-7 cells in different ...
(A) Chemical structure of Isoginkgetin. (B) IC50-values of U87MG cells ...
(A) Chemical structure of Isoginkgetin. (B) IC50-values of U87MG cells ...
Effect of compounds 17, 23 and 29 on U87MG cells migration in vitro ...
Effect of compounds 17, 23 and 29 on U87MG cells migration in vitro ...
Exploring the Therapeutic Potential of Cannabidiol in U87MG Cells ...
Exploring the Therapeutic Potential of Cannabidiol in U87MG Cells ...
Effect on the cell progression. After U87MG and GSCs were treated with ...
Effect on the cell progression. After U87MG and GSCs were treated with ...
U87MG and U118MG cells were grown separately on chamber slides and ...
U87MG and U118MG cells were grown separately on chamber slides and ...
The morphological change of U87MG cells after the physically-based CAP ...
The morphological change of U87MG cells after the physically-based CAP ...
U87MG cells were transfected to overexpress ITGB4. The expression level ...
U87MG cells were transfected to overexpress ITGB4. The expression level ...
(A). IC50-values of U87Mg cells after 24, 48 and 72 h of incubation ...
(A). IC50-values of U87Mg cells after 24, 48 and 72 h of incubation ...
Inhibitor of differentiation 1 in U87MG glioblastoma cells promotes ...
Inhibitor of differentiation 1 in U87MG glioblastoma cells promotes ...
(A). IC50-values of U87Mg cells after 24, 48 and 72 h of incubation ...
(A). IC50-values of U87Mg cells after 24, 48 and 72 h of incubation ...
(A). IC50-values of U87Mg cells after 24, 48 and 72 h of incubation ...
(A). IC50-values of U87Mg cells after 24, 48 and 72 h of incubation ...
Ponatinib suppresses U87Mg cell viability. Notes: (A) U87Mg cells were ...
Ponatinib suppresses U87Mg cell viability. Notes: (A) U87Mg cells were ...
(A) Representative images of FACS analysis in U87MG cells at 48 and 72 ...
(A) Representative images of FACS analysis in U87MG cells at 48 and 72 ...
The effect of FC85 and/or ISA27 on U87MG cell apoptosis and cell cycle ...
The effect of FC85 and/or ISA27 on U87MG cell apoptosis and cell cycle ...
Synergistic effect of FC85 and ISA27 on the survival/growth of U87MG ...
Synergistic effect of FC85 and ISA27 on the survival/growth of U87MG ...

Loading image details...

Source
Dimensions